Therapeutic Peptide Formulations

Abstract: Stable pharmaceutical formulations for therapeutic dual GLP-1 receptor/glucagon receptor agonists and methods of using such stable pharmaceutical formulations.

Patent Information

Application #

Filing Date

27 June 2023

Publication Number

31/2024

Publication Type

INA

Invention Field

BIO-CHEMISTRY

Status

Email

Parent Application

Applicants

ELI LILLY AND COMPANY

LILLY CORPORATE CENTER Indianapolis, Indiana 46285

Inventors

1. ALLEN, David Paul

c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288

2. DESAI, Dhara Pankaj

c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288

3. QIAN, Ken Kangyi

c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288

Specification

Documents

Application Documents

#	Name	Date
1	202317042947-STATEMENT OF UNDERTAKING (FORM 3) [27-06-2023(online)].pdf	2023-06-27
2	202317042947-Sequence Listing in txt [27-06-2023(online)].txt	2023-06-27
3	202317042947-Sequence Listing in PDF [27-06-2023(online)].pdf	2023-06-27
4	202317042947-REQUEST FOR EXAMINATION (FORM-18) [27-06-2023(online)].pdf	2023-06-27
5	202317042947-PROOF OF RIGHT [27-06-2023(online)].pdf	2023-06-27
6	202317042947-POWER OF AUTHORITY [27-06-2023(online)].pdf	2023-06-27
7	202317042947-FORM-26 [27-06-2023(online)].pdf	2023-06-27
8	202317042947-FORM 18 [27-06-2023(online)].pdf	2023-06-27
9	202317042947-FORM 1 [27-06-2023(online)].pdf	2023-06-27
10	202317042947-DRAWINGS [27-06-2023(online)].pdf	2023-06-27
11	202317042947-DECLARATION OF INVENTORSHIP (FORM 5) [27-06-2023(online)].pdf	2023-06-27
12	202317042947-COMPLETE SPECIFICATION [27-06-2023(online)].pdf	2023-06-27
13	202317042947-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [27-06-2023(online)].pdf	2023-06-27
14	202317042947-FORM 3 [29-11-2023(online)].pdf	2023-11-29